Nalaganje...
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
Circulating tumor DNA (ctDNA) analysis is being incorporated into cancer care; notably in profiling patients to guide treatment decisions. Responses to targeted therapies have been observed in patients with actionable mutations detected in plasma DNA at variant allele fractions (VAFs) below 0.5%. Hi...
Shranjeno v:
| izdano v: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854321/ https://ncbi.nlm.nih.gov/pubmed/29543828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193802 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|